- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Varenicline
Total 340 results
-
PfizerCompleted
-
PfizerCompletedSmoking CessationUnited States
-
PfizerCompletedSmoking CessationUnited States
-
Mark EisenbergSunnybrook Health Sciences Centre; Unity Health Toronto; Queen Elizabeth II Health...CompletedAcute Coronary SyndromeCanada
-
PfizerCompletedSmoking CessationUnited States
-
VA Boston Healthcare SystemWithdrawnTobacco Use DisorderUnited States
-
PfizerCompleted
-
Albert Einstein College of MedicineFDNY World Trade Center Health ProgramNot yet recruiting
-
Sahlgrenska University Hospital, SwedenKarolinska University Hospital; Malmö UniversityCompletedAlcohol DependenceSweden
-
Yale UniversityActive, not recruiting
-
PfizerCompletedSmoking CessationUnited States, Czech Republic, Korea, Republic of, Brazil, Taiwan, Mexico, France, Italy, Hungary, Germany, Canada, China, Argentina, United Kingdom
-
PfizerCompletedDepression | Smoking CessationSpain, United States, Hungary, Germany, Bosnia and Herzegovina, Croatia, Romania, Russian Federation
-
PfizerCompleted
-
PfizerCompletedHealthy | Non-SmokingUnited States
-
PfizerCompletedSmoking CessationUnited States, United Kingdom
-
PfizerCompleted
-
PfizerCompletedSmoking CessationUnited States
-
Medical University of South CarolinaCompleted
-
PfizerCompletedSmoking CessationUnited States
-
Centre for Addiction and Mental HealthCanadian Institutes of Health Research (CIHR); Canadian Tobacco Control Research...CompletedNicotine DependenceCanada
-
University of Maryland, BaltimoreNational Institute on Drug Abuse (NIDA)CompletedSchizophrenia | Cigarette Smoking
-
Universita degli Studi di CataniaCompletedSmoking Cessation | DiabetesItaly
-
Amsterdam UMC, location VUmcCentre for Human Drug Research, NetherlandsTerminatedParkinson's DiseaseNetherlands
-
PfizerCompletedSmoking CessationThailand, Singapore, China
-
PfizerCompletedSmoking CessationUnited States, Taiwan, Australia, Germany, Egypt, United Kingdom, Canada, Czech Republic, Mexico, Japan
-
Nikki Nollen, PhD, MACompleted
-
PfizerCompletedSmoking Cessation | Pharmacokinetics | BioavailabilityUnited States
-
University of Kansas Medical CenterRecruiting
-
Oyster Point Pharma, Inc.CompletedDry Eye Disease (DED)United States
-
West Virginia UniversityNational Institute on Drug Abuse (NIDA); PfizerCompletedSmoking Cessation | Opioid Related DisordersUnited States
-
SRI InternationalNational Cancer Institute (NCI)CompletedUnspecified Adult Solid Tumor, Protocol SpecificUnited States
-
The Queen Elizabeth HospitalCompleted
-
Massachusetts General HospitalNational Cancer Institute (NCI)Completed
-
PfizerKarolinska Institutet; University of AarhusCompletedMalformations
-
University of British ColumbiaPfizerCompleted
-
Oyster Point Pharma, Inc.CompletedDry Eye DiseaseUnited States
-
University of California, San FranciscoNational Institute on Alcohol Abuse and Alcoholism (NIAAA)CompletedSubstance DependenceUnited States
-
PfizerCompletedSmoking CessationUnited States, Canada
-
University of PennsylvaniaNational Institute on Drug Abuse (NIDA)WithdrawnVarenicline and the Blunting of Cocaine CuesUnited States
-
Mayo ClinicNational Institutes of Health (NIH)Completed
-
Sir Mortimer B. Davis - Jewish General HospitalRecruiting
-
Brandon BaartmanRecruiting
-
Massachusetts General HospitalNational Institute on Drug Abuse (NIDA)Active, not recruitingNicotine Dependence | VapingUnited States
-
Yale UniversityNational Institute on Alcohol Abuse and Alcoholism (NIAAA)Completed
-
UConn HealthNational Institute on Drug Abuse (NIDA); National Institutes of Health (NIH)Completed
-
Stephenson Eye AssociatesRecruiting
-
University of PennsylvaniaNational Institute on Drug Abuse (NIDA)Completed
-
Medical University of South CarolinaRecruitingSmoking | Smoking Cessation | Tobacco Smoking | Cigarette SmokingUnited States
-
University Health Network, TorontoPfizerUnknown
-
Oyster Point Pharma, Inc.CompletedDry Eye DiseaseUnited States